Biotech firm engineers fungi and plant genomes to develop therapeutic compounds targeting neurological and psychiatric disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Empyrean Neuroscience is a biotechnology company that utilizes genetic engineering to develop neuroactive compounds aimed at treating neuropsychiatric and neurologic disorders. By precisely modifying the genomes of fungi and plants, the company creates small molecule therapeutics targeting conditions such as major depressive disorder, PTSD, and chronic pain. The company’s approach integrates advanced genetic techniques to enhance the efficacy and safety of these compounds.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Empyrean Neuroscience Management Team
Empyrean Neuroscience Valuations & Financials
View real-time NPM data on Empyrean Neuroscience stock including daily Empyrean Neuroscience stock price estimates, valuation history, and historical share price information. Access Empyrean Neuroscience financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Empyrean Neuroscience pricing across six independent market signals. Looking for private company due diligence data sources on Empyrean Neuroscience? Get in touch to learn more.
Similar Companies
like Empyrean Neuroscience
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
OpenEvidence
Healthcare & Life Sciences
Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
FAQ
We have answers
Empyrean Neuroscience stock does not trade on public stock exchanges. Empyrean Neuroscience stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Empyrean Neuroscience stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Empyrean Neuroscience Stock does not trade on public stock exchanges. In order to sell Empyrean Neuroscience shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Empyrean Neuroscience does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Empyrean Neuroscience share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Empyrean Neuroscience stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Empyrean Neuroscience stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Empyrean Neuroscience stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Empyrean Neuroscience is a private company and has not had an IPO. There is currently no Empyrean Neuroscience IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Empyrean Neuroscience IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
